Please use this identifier to cite or link to this item:
|Title:||Forebrain medial septum region facilitates nociception in a rat formalin model of inflammatory pain|
|Authors:||Lee, A.T.-H. |
|Citation:||Lee, A.T.-H., Ariffin, M.Z., Zhou, M., Ye, J.Z., Moochhala, S.M., Khanna, S. (2011-11). Forebrain medial septum region facilitates nociception in a rat formalin model of inflammatory pain. Pain 152 (11) : 2528-2542. ScholarBank@NUS Repository. https://doi.org/10.1016/j.pain.2011.07.019|
|Abstract:||The medial septum is anatomically and functionally linked to the hippocampus, a region implicated in nociception. However, the role of medial septum in nociception remains unclear. To investigate the role of the region in nociception in rats, muscimol, a GABA agonist, or zolpidem, a positive allosteric modulator of GABA A receptors, was microinjected into medial septum to attenuate the activity of neurons in the region. Electrophysiological studies in anesthetized rats indicated that muscimol evoked a stronger and longer-lasting suppression of medial septal-mediated activation of hippocampal theta field activity than zolpidem. Similarly, microinjection of muscimol (1 or 2 μg/0.5 μl) into the medial septum of awake rats suppressed both licking and flinching behaviors in the formalin test of inflammatory pain, whereas only the latter behavior was affected by zolpidem (8 or 12 μg/0.5 μl) administered into the medial septum. Interestingly, both drugs selectively attenuated nociceptive behaviors in the second phase of the formalin test that are partly driven by central plasticity. Indeed, muscimol reduced the second phase behaviors by 30% to 60%, which was comparable to the reduction seen with systemic administration of a moderate dose of the analgesic morphine. The reduction was accompanied by a decrease in formalin-induced expression of spinal c-Fos protein that serves as an index of spinal nociceptive processing. The drug effects on nociceptive behaviors were without overt sedation and were distinct from the effects observed after septal lateral microinjections. Taken together, these findings suggest that the activation of medial septum is pro-nociceptive and facilitates aspects of central neural processing underlying nociception. © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 22, 2018
WEB OF SCIENCETM
checked on May 15, 2018
checked on May 17, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.